No Data
yantai zhenghai bio-tech (300653.SZ): has cumulatively repurchased 0.927% shares
On November 4th, Yantai Zhenghai Bio-Tech (300653.SZ) announced that as of October 31, 2024, the company repurchased 1,668,600 shares through the share repurchase dedicated securities account through centralized competitive trading, accounting for 0.9270% of the total share capital. The highest fill price was 24.83 yuan per share, the lowest fill price was 17.90 yuan per share, and the total amount paid was 34.2793 million yuan (excluding transaction costs).
Why Yantai Zhenghai Biotechnology's (SZSE:300653) Shaky Earnings Are Just The Beginning Of Its Problems
Zhenghai Biotech: Report for the third quarter of 2024
Yantai Zhenghai Bio-Tech (300653.SZ): Intends to cancel the wholly-owned subsidiary Suzhou Zhenghai Biotechnology Co., Ltd.
On October 22, Gelonhui announced that yantai zhenghai bio-tech (300653.SZ) has decided to cancel its wholly-owned subsidiary, Suzhou Zhenghai Bio-Technology Co., Ltd., in order to optimize the allocation of company resources, improve operational efficiency, and reduce management costs. The cancellation of this subsidiary will not have any adverse impact on the company's future business development and overall profit capability. After the cancellation is completed, Suzhou Zhenghai Bio-Technology Co., Ltd. will no longer be included in the company's consolidated financial statements.
yantai zhenghai bio-tech (300653.SZ): The net income in the third quarter was 39.0236 million yuan, a year-on-year increase of 1.38%.
On October 22, Yantai Zhenghai Bio-Tech (300653.SZ) released its third quarter report for 2024. In the third quarter of 2024, the company achieved revenue of 93.3242 million yuan, a decrease of 4.06% year-on-year; the net income attributable to shareholders of the listed company was 39.0236 million yuan, an increase of 1.38% year-on-year; the net income, excluding non-recurring gains and losses, was 32.6139 million yuan, a decrease of 14.75% year-on-year; the basic earnings per share was 0.22 yuan per share.
Yantai Zhenghai Bio-Tech (300653.SZ) released its performance for the first three quarters, with a net income of 0.125 billion yuan, a decrease of 15.69%.
Yantai Zhenghai Bio-Tech (300653.SZ) released the third quarter report for 2024, with the company's revenue in the first three quarters reaching 2...
Little Excitement Around Yantai Zhenghai Biotechnology Co., Ltd.'s (SZSE:300653) Earnings As Shares Take 29% PoundingNo Data
No Data
